# FDA Inspection 1223721 - Laboval Inc. - October 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/laboval-inc/501080c7-d8b9-4eef-a15e-c17e7b77f60d
Source feed: FDA_Inspections

> FDA Inspection 1223721 for Laboval Inc. on October 31, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223721
- Company Name: Laboval Inc.
- Inspection Date: 2023-10-31
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 968740 - 2016-02-19](https://www.keypedia.com/records/fda_inspections/laboval-inc/40cc79b7-2670-4572-87cc-1ea05bea3817)

Company: https://www.keypedia.com/companies/laboval-inc/a7f63bed-1d71-4499-8ab0-2f60c71a2d0e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c